{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:34:39Z","timestamp":1790998479509,"version":"4.1.0"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.carrev.2025.02.007","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T03:02:52Z","timestamp":1739847772000},"page":"110-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Adverse events and failure modes related to Impella CP: Insights from the FDA MAUDE database"],"prefix":"10.1016","volume":"76","author":[{"given":"Kalyan R.","family":"Chitturi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Merdler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nauman","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder D.","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsik","family":"Ben-Dor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2025.02.007_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011534","article-title":"Prophylactic mechanical circulatory support use in elective percutaneous coronary intervention for patients with stable coronary artery disease","volume":"15","author":"Zeitouni","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2025.02.007_bb0010","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial flow pump or standard care in infarct-related cardiogenic shock","volume":"390","author":"Moller","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2025.02.007_bb0015","author":"US Food and Drug Administration"},{"key":"10.1016\/j.carrev.2025.02.007_bb0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4244\/EIJ-D-18-01021","article-title":"Adverse events and modes of failure related to the Impella percutaneous left ventricular assist devices: a retrospective analysis of the MAUDE database","volume":"15","author":"Khalid","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2025.02.007_bb0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjcard.2020.10.056","article-title":"Analysis of adverse events related to Impella usage (from the manufacturer and user facility device experience and national inpatient sample databases)","volume":"140","author":"Philipson","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2025.02.007_bb0030","author":"US Food and Drug Administration"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925000569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925000569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:27:25Z","timestamp":1762550845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838925000569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":6,"alternative-id":["S1553838925000569"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.02.007","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events and failure modes related to Impella CP: Insights from the FDA MAUDE database","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}